
Core Scientific, Inc.
CORZNASDAQTechnology● Active
$28.08
+$0.93(+3.43%)
Market Cap$8.9B
P/E Ratio—
52W High$30.46
52W Low$10.93
Core Scientific, Inc. (CORZ) · Cash Flow
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · CORZ · as of 2026-06-10
Financial statements
Operating CF · CapEx · Free Cash Flow
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | ($0.29B) | ($1.32B) | ($0.25B) | ($2.15B) | $0.05B |
| Depreciation & Amort. | $0.07B | $0.12B | $0.10B | $0.23B | $0.03B |
| Stock-Based Comp. | $0.10B | $0.05B | $0.06B | $0.18B | $0.04B |
| Change in Working Capital | $0.52B | ($0.03B) | $0.55B | $0.08B | ($0.05B) |
| Net Cash from Operations | $0.28B | $0.04B | $0.07B | $0.21B | ($0.06B) |
| Investing Activities | |||||
| Capital Expenditure | ($0.73B) | ($0.09B) | ($0.02B) | ($0.60B) | ($0.06B) |
| Purchases of Investments | ($0.01B) | $0.00B | $0.00B | $0.00B | $0.00B |
| Sales of Investments | $0.00B | $0.00B | $0.00B | $0.01B | $0.00B |
| Net Cash from Investing | ($0.74B) | ($0.10B) | ($0.00B) | ($0.59B) | ($0.42B) |
| Financing Activities | |||||
| Common Stock Repurchased | $0.00B | $0.00B | $0.00B | ($0.03B) | $0.00B |
| Dividends Paid | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Debt Issued / Repaid | ($0.01B) | $0.77B | ($0.04B) | $0.12B | $0.61B |
| Net Cash from Financing | ($0.06B) | $0.82B | ($0.04B) | $0.31B | $0.60B |
| Free Cash Flow | |||||
| Free Cash Flow | ($0.45B) | ($0.05B) | $0.05B | ($0.40B) | ($0.12B) |
| FCF Margin %(computed) | -141.29% | -10.20% | 9.74% | -61.92% | -21.31% |
Data source: Financial Modeling Prep · Last updated: 2026-06-10 · USD · B
Explore more Core Scientific, Inc. data
About Core Scientific, Inc. (CORZ) Cash Flow Statement
Core Scientific, Inc. generated operating cash flow of $0.28B and free cash flow of ($0.45B) for 2025 — a FCF margin of -141.29%. Capital expenditure was ($0.73B).
Frequently asked questions
CORZ · 4 questionsCore Scientific, Inc. generated free cash flow of ($0.45B) for 2025, down 765.7% year-over-year.
CORZ free cash flowFCF margincash flow yield
· Source: FMP /stable/cash-flow-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10